Business Description
Memphasys Ltd
ISIN : AU000000MEM5
Total Employee Number:
28Description
Memphasys Ltd is an Australian reproductive biotechnology company developing and commercializing novel reproduction and fertility solutions for humans and animals. The products in its development pipeline include a range of devices, media, and in vitro diagnostic solutions. The company is currently focused on the commercialisation of its patented Felix System, a novel bio-separation technology for assisted reproduction, designed to revolutionise sperm separation in assisted reproductive technology (ART) by providing a rapid, gentle, and automated process. The group has only one operating segment, being Reproductive Technologies, the assets and liabilities of which are located in Australia.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.09 | |||||
Equity-to-Asset | 0.39 | |||||
Debt-to-Equity | 1.09 | |||||
Debt-to-EBITDA | -1.35 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -7.15 | |||||
Beneish M-Score | -6.72 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 20.6 | |||||
3-Year EPS without NRI Growth Rate | 20.6 | |||||
3-Year FCF Growth Rate | 30.7 | |||||
3-Year Book Growth Rate | -39.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 86.22 | |||||
9-Day RSI | 75.32 | |||||
14-Day RSI | 65.79 | |||||
3-1 Month Momentum % | 100 | |||||
6-1 Month Momentum % | -42.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.14 | |||||
Quick Ratio | 0.1 | |||||
Cash Ratio | 0.07 | |||||
Days Inventory | 1389.26 | |||||
Days Sales Outstanding | 3589.17 | |||||
Days Payable | 3449.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -31.8 | |||||
Shareholder Yield % | -16.77 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | -258.33 | |||||
Operating Margin % | -33858.33 | |||||
Net Margin % | -36758.33 | |||||
EBITDA Margin % | -27033.33 | |||||
FCF Margin % | -26871.43 | |||||
OCF Margin % | -23900 | |||||
ROE % | -91.65 | |||||
ROA % | -40.53 | |||||
ROIC % | -26.96 | |||||
3-Year ROIIC % | -1176.52 | |||||
ROC (Joel Greenblatt) % | -649.92 | |||||
ROCE % | -76.14 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 9.1 | |||||
EV-to-EBIT | -7.39 | |||||
EV-to-EBITDA | -8.84 | |||||
EV-to-Revenue | 2388.16 | |||||
EV-to-FCF | -7.23 | |||||
Earnings Yield (Greenblatt) % | -13.54 | |||||
FCF Yield % | -13.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Memphasys Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 0.007 | ||
| EPS (TTM) (€) | -0.002 | ||
| Beta | 10.9787 | ||
| 3-Year Sharpe Ratio | 0.52 | ||
| 3-Year Sortino Ratio | 2.44 | ||
| Volatility % | 224.66 | ||
| 14-Day RSI | 65.79 | ||
| 14-Day ATR (€) | 0.000313 | ||
| 20-Day SMA (€) | 0.0022 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 0.001 - 0.005 | ||
| Shares Outstanding (Mil) | 3,087.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Memphasys Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Memphasys Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Memphasys Ltd Frequently Asked Questions
What is Memphasys Ltd(FRA:IG7)'s stock price today?
The current price of FRA:IG7 is €0.00. The 52 week high of FRA:IG7 is €0.01 and 52 week low is €0.00.
When is next earnings date of Memphasys Ltd(FRA:IG7)?
The next earnings date of Memphasys Ltd(FRA:IG7) is .
Does Memphasys Ltd(FRA:IG7) pay dividends? If so, how much?
Memphasys Ltd(FRA:IG7) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Memphasys Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers